Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

GLYBURIDE MICRO 1.5 MG TAB

Glyburide
$0.1600per EA

Strength

1.5 mg/1

Manufacturer

Teva Pharmaceuticals USA Inc.

NDC

00093803401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

1/22/2025

Active Ingredients

GLYBURIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074686

On Market Since

5/11/1999

Pharmacological Classes

Sulfonylurea Compounds
Sulfonylurea

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+214.9%

5Y

+214.9%

All

+253.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

GLIMEPIRIDE 1 MG TABLET
Generic
16571077301•Rising Pharma Holdings Inc.
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
16571077350•Rising Pharma Holdings Inc.
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
16729000116•Accord Healthcare Inc.
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
42571010001•Micro Labs Limited
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
43547039410•Solco Healthcare US LLC
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
43547039450•Solco Healthcare US LLC
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
50268035815•AvPAK
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
55111032001•Dr. Reddy's Laboratories Inc.
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
55111032005•Dr. Reddy's Laboratories Inc.
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
61442011501•Carlsbad Technology Inc.
$0.0225
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy